Re: Lymph Node Prep
Bruce Davis, MD - Clinical Pathology (bdavis@beaumont.edu)
Tue, 19 Mar 1996 17:53:12 -0500 (EST)
In >99.8% of cases, I see no reason for ficoll separation of LN samples
when using viability gating. What are the 0.2%? I don't know as I
haven't found one, but never say never.
Bruce H. Davis, M.D.
Wm. Beaumont Hosp.
Royal Oak, MI
CD ROM Vol 2 was produced by staff at the Purdue University Cytometry Laboratories
and distributed free of charge as an educational service to the cytometry community.
If you have any comments please direct them to Dr. J. Paul Robinson, Professor & Director, PUCL,
Purdue University, West Lafayette, IN 47907. Phone:(317) 494-0757; FAX (317) 494-0517; Web http://www.cyto.purdue.edu
EMAIL robinson@flowcyt.cyto.purdue.edu
